ClinicalTrials.gg
RecruitingNCT06107647Updated Oct 31, 2023

Comparisons of Two Different Type Heater in Different Inhalation Anesthesia in Terms of Prevention of Hypothermia

An interventional study of COVIDIEN WarmTouch in Anesthesia, Hypothermia and Heat, sponsored by Fatih Sultan Mehmet Training and Research Hospital. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-31.

Sponsored by Fatih Sultan Mehmet Training and Research Hospital · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 10 months ago, but the record still lists the study as recruiting.
  • Started Jun 2023; still recruiting 3 years 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Unintentional perioperative hypothermia is a common occurrence. One of the recommendations of the guidelines to prevent hypothermia is the use of active warmers. It is known that low-flow anesthesia protects from hypothermia compared to high-flow anesthesia. In this study, we aimed to compare the efficacy of using active air blown heater and resistive heater in preventing hypothermia in patients with low flow and high flow inhalation anesthesia

Read the detailed description

ABSTRACT

PROSPECTIVE COMPARISON OF ACTIVE AIR BLOWN HEATER AND RESISTIVE TYPE HEATERS FOR PREVENTION OF HYPOTHERMIA IN HIGH CURRENT AND LOW CURRENT INHALATION ANESTHESIA

Aim: Unintentional perioperative hypothermia is a common occurrence. One of the recommendations of the guidelines to prevent hypothermia is the use of active warmers. It is known that low-flow anesthesia protects from hypothermia compared to high-flow anesthesia. In this study, we aimed to compare the efficacy of using active air blown heater and resistive heater in preventing hypothermia in patients with low flow and high flow inhalation anesthesia.

Materials and Methods: After ethics committee approval (Date: 08.12.2022/23), 112 patients with American Society of Anesthesiologist (ASA; American Society of Anesthesiologists) I-III, who were to undergo rhinoplasty between June 01, 2023 and January 01, 2024, were included in the study after informed consent was obtained. Group DA was defined as low flow anesthesia and active air blast heater, group DR as low flow anesthesia and resistive heater, group YA as high flow anesthesia and active air blast heater, and group YR as high flow anesthesia and resistive heater. Each group consisted of 28 patients. Heart rate, systolic, diastolic and mean arterial pressure, peripheral oxygen saturation values and body temperature values were measured and recorded at certain time intervals during the perioperative period and in the recovery unit. Body temperatures were also recorded in the ward. Thermal comfort scores were evaluated on admission, in the recovery unit and in the ward, while shivering score and patient satisfaction score were evaluated only in the recovery unit.

02

Conditions studied

  • Anesthesia
  • Hypothermia
  • Heat

Browse trials for

Keywords

  • High flow
  • hypothermia
  • low flow
  • rhinoplasty
03

In context

Hypothermia

449 studies on the registry are indexed under Hypothermia; 54 are open to participants now.

This study's planned enrollment of 112 is above the median of 77 across 328 interventional studies indexed under Hypothermia.

Browse Hypothermia studies →

Lead sponsor

Fatih Sultan Mehmet Training and Research Hospital is the lead sponsor of 120 studies on the registry; 34 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients between the ages of 18-65, who are included in the group, who will undergo rhinoplasty.

Exclusion criteria

Exclusion Criteria:

  • Patients with > 35 KG/M²
  • Patients with body temperature >37.5°C, \<36°C degrees
  • Those with cardiovascular system or central nervous system disease
  • Patients with thyroid disorders
  • Patients with autonomic dysfunction
  • Patients not between the ages of 18-65
  • Patients with missing information in the information form
  • Patients using or vasoactive drugs.
  • Patients whose operation time is less than 30 minutes
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
112 participants (estimated)

Study arms

  • Experimental
    GRUP DA

    Patients who will be given low-flow anesthesia during the operation and will be heated with an active air blower heater.

    Device: COVIDIEN WarmTouch

  • Experimental
    GRUP YA

    Patients who will be given high current anesthesia during the operation and will be heated with an active air blower heater.

    Device: COVIDIEN WarmTouch

  • Experimental
    GRUP DR

    Patients who will be given low-flow anesthesia during the operation and will be heated with a resistive heater

    Device: COVIDIEN WarmTouch

  • Experimental
    GRUP YR

    Patients who will be treated with high-flow anesthesia and heated with a resistive heater during the operation

    Device: COVIDIEN WarmTouch

Interventions

  • DeviceCOVIDIEN WarmTouch

    "COVIDIEN WarmTouch will be used as an active air blowing heater. Patients will be warmed starting from the beginning of anesthesia." "The INDITHERM Medical Alpha, which is a resistive heater, will be applied to patients starting at the beginning of anesthesia."

    Also known as: INDITHERM Medical Alpha

06

What researchers measure

Primary outcomes

  1. Measurement of body temperatures in patients using two different body heaters during anesthesia applications.

    In our study, two patient groups receiving high current and low current anesthesia will be heated with only one type of heater, either active air blowing heater or resistive heater, from the beginning of anesthesia. Their body temperatures will be measured and recorded throughout the operation. In our study, COVIDIEN WarmTouch will be used as an active air blowing heater. INDITHERM Medical Alpha will be used as a resistive-type heater. Throughout the entire operation, body temperature will be monitored using the zero-heat flow method from the temporal artery to the body surface (3M Spot ON).

    Time frame: 6 mounth

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06107647
Responsible party
Abdullah Pabucci (Assistant Doctor, Fatih Sultan Mehmet Training and Research Hospital) — Principal investigator
First posted
Oct 30, 2023
Start date
Jun 1, 2023
Primary completion
Jan 1, 2024 (estimated)
Completion
Mar 1, 2024 (estimated)
Last update
Oct 31, 2023

Study contacts

abdullah md pabucci
Contact
dr.pabucci@gmail.com
+905531918241
arzu md yıldırım ar
Contact
dr.arzuyildirim@hotmail.com
+905053822729
abdullah pabucci
principal investigator · fatih sultan mehmet research and traning hospital

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion